Vasiliy V Polosukhin Selected Research

Reactive Oxygen Species (Oxygen Radicals)

1/2022	Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis.
12/2015	Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasiliy V Polosukhin Research Topics

Disease

22	Inflammation (Inflammations) 01/2023 - 04/2006
14	Fibrosis (Cirrhosis) 04/2024 - 01/2005
13	Pneumonia (Pneumonitis) 01/2023 - 11/2005
10	Neoplasms (Cancer) 01/2024 - 03/2007
10	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 08/2011
8	Carcinogenesis 01/2022 - 03/2007
6	Asthma (Bronchial Asthma) 01/2022 - 12/2009
5	Lung Injury 02/2016 - 04/2006
5	Hyperplasia 12/2011 - 12/2009
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 04/2005
4	Emphysema 01/2021 - 04/2016
4	Respiratory Hypersensitivity 10/2018 - 05/2009
4	Airway Remodeling 01/2018 - 05/2010
4	Hypoxia (Hypoxemia) 12/2015 - 05/2007
3	Lung Neoplasms (Lung Cancer) 12/2019 - 11/2007
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2008
2	Hypertrophy 12/2021 - 05/2010
2	Sarcoidosis (Schaumann Disease) 01/2016 - 09/2014
2	Infections 06/2012 - 05/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2012 - 06/2011
2	Idiopathic Pulmonary Fibrosis 10/2010 - 04/2010
2	Lung Diseases (Lung Disease) 05/2010 - 05/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2008 - 11/2007
2	Acute Lung Injury 10/2007 - 04/2006
1	Vascular Diseases (Vascular Disease) 05/2023
1	Cystic Fibrosis (Mucoviscidosis) 01/2023
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Necrosis 01/2021
1	Tertiary Lymphoid Structures 01/2021
1	Lewis Lung Carcinoma 12/2019

Drug/Important Bio-Agent (IBA)

15	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 01/2005
12	CollagenIBA 04/2024 - 01/2005
12	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2007
8	CytokinesIBA 01/2023 - 05/2007
6	Secretory Immunoglobulin A (SIgA)IBA 01/2021 - 08/2011
6	NF-kappa B (NF-kB)IBA 12/2009 - 04/2006
5	Urethane (Ethyl Carbamate)IBA 12/2019 - 11/2007
4	AllergensIBA 01/2023 - 12/2009
4	Interleukin-13IBA 01/2022 - 05/2009
4	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 11/2018 - 08/2011
4	Surface-Active Agents (Surfactants)IBA 06/2011 - 11/2005
3	Messenger RNA (mRNA)IBA 11/2023 - 05/2010
3	Interleukin-33IBA 01/2023 - 01/2021
3	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 05/2007
3	LipopolysaccharidesIBA 02/2016 - 05/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2012 - 06/2011
3	Protein CIBA 06/2011 - 11/2005
2	SmokeIBA 11/2023 - 11/2018
2	LigandsIBA 01/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 12/2015
2	CarcinogensIBA 01/2022 - 01/2018
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2010
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 10/2018
2	IntegrinsIBA 01/2022 - 01/2020
2	Interleukin-5 (Interleukin 5)IBA 01/2022 - 01/2021
2	AntigensIBA 01/2021 - 08/2011
2	Interleukin-17 (Interleukin 17)IBA 10/2018 - 06/2013
2	AntibodiesIBA 01/2018 - 12/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2016
2	MucinsIBA 12/2015 - 05/2009
2	Clodronic Acid (Clodronate)IBA 12/2014 - 12/2011
2	X-Box Binding Protein 1IBA 06/2012 - 06/2011
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2012 - 06/2011
2	Carbonic Anhydrase IXIBA 06/2011 - 10/2007
2	I-kappa B KinaseIBA 05/2007 - 04/2006
1	Sulfur DioxideIBA 05/2023
1	AlarminsIBA 01/2023
1	ProstaglandinsIBA 01/2022
1	AgarIBA 01/2022
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	Dehydroepiandrosterone (DHEA)IBA 01/2022
1	ThromboxanesIBA 01/2022
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2022
1	ifetrobanIBA 01/2022
1	AndrogensIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	4,4',4''- (4- propyl- ((1)H)- pyrazole- 1,3,5- triyl) tris-phenolIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	NAD (NADH)IBA 01/2021
1	CCR2 ReceptorsIBA 01/2020
1	GSK 1363089IBA 12/2019
1	Warfarin (Coumadin)FDA LinkGeneric 12/2019
1	c-Mer Tyrosine KinaseIBA 12/2019
1	Vitamin K FDA Link 12/2019
1	Interleukin-15 (Interleukin 15)IBA 11/2018
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 11/2018
1	Immunoglobulin E (IgE)IBA 10/2018
1	Hormones (Hormone)IBA 10/2018
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	Testosterone (Sustanon)FDA Link 10/2018
1	Tyrosine Kinase InhibitorsIBA 06/2016
1	ErbB Receptors (EGF Receptor)IBA 06/2016
1	RoflumilastIBA 04/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 04/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2013